Eagle Genomics
Focus: Eagle Genomics is a UK-based genomics software company founded in 2023, operating in the biotechnology segment with a focus on computational and informatics solutions.
Profile data last refreshed 3h ago · AI intelligence enriched 2mo ago
Open Jobs
9+9 this month
Growing — net +9 jobs in 30d
9 jobs added vs 0 removed. Steady team buildout.
Should You Work at Eagle Genomics?
AI assessmentEagle Genomics is a pre-revenue founder bet suitable only for risk-tolerant early-stage builders; traditional career progression should be expected elsewhere.
Why Work Here
- Early-stage opportunity to shape the foundational direction of a genomics software platform in a high-growth biotech domain
- Cambridge location provides access to world-class research institutions and a dense biotech talent ecosystem
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Eagle Genomics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.